Fangzhou Inc

06086

Company Profile

  • Business description

    Fangzhou Inc is a online chronic disease management platform in China. It has focus on chronic disease management to address the needs of patients with chronic diseases, such as hypertension, cardiovascular and respiratory chronic diseases. The company provide comprehensive medical services and online retail pharmacy services through Jianke Platform. The principal segment of the group are online retail pharmacy services, comprehensive medical services, Wholesale and customized content and marketing solutions. Key revenue is generated from Online retail pharmacy services.

  • Contact

    4th Street
    Floor 1-2, Building S, Kehui Jingu
    No. 99, Science Avenue, Luogang Science City
    Huangpu District, Guangdong Province
    Guangzhou
    CHN

    https://investors.jianke.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Pharmaceutical Retailers

    Fiscal Year End

    31 December 2026

    Employees

    494

Stocks News & Analysis

stocks

Cheap ASX share pays a heavy price for NRL rights

Growth has slowed amid increased competition for viewers and content.
stocks

The World Cup stock you’ve never heard of

This ASX stock is kicking goals at the FIFA World Cup.
stocks

Chart of the Week: Can WiseTech shares finally bounce back?

Market concerns over governance and AI fears have left shares trading well below the fair value.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,003.7034.900.39%
CAC 408,338.9712.350.15%
DAX 4025,067.0951.18-0.20%
Dow JONES (US)52,637.01149.600.29%
FTSE 10010,497.2924.840.24%
HKSE24,175.12144.940.60%
NASDAQ26,281.6174.720.29%
Nikkei 22568,557.73813.881.20%
NZX 50 Index13,785.67120.490.88%
S&P 5007,575.3931.750.42%
S&P/ASX 2008,806.0038.200.44%
SSE Composite Index3,996.1640.43-1.00%

Market Movers